Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Materials and Methods, Supplementary Figure Legends, and Supplementary Table Legends from The Use of Olaparib (AZD2281) Potentiates SN-38 Cytotoxicity in Colon Cancer Cells by Indirect Inhibition of Rad51-Mediated Repair of DNA Double-Strand Breaks
  1. Home
  2. Publications
  3. Supplementary Materials and Methods, Supplementary Figure Legends, and Supplementary Table Legends from The Use of Olaparib (AZD2281) Potentiates SN-38 Cytotoxicity in Colon Cancer Cells by Indirect Inhibition of Rad51-Mediated Repair of DNA Double-Strand Breaks

Supplementary Materials and Methods, Supplementary Figure Legends, and Supplementary Table Legends from The Use of Olaparib (AZD2281) Potentiates SN-38 Cytotoxicity in Colon Cancer Cells by Indirect Inhibition of Rad51-Mediated Repair of DNA Double-Strand Breaks

Authors:
  • MTMakiko Tahara
    Makiko Tahara
  • TITakeshi Inoue
    Takeshi Inoue
  • FSFutoshi Sato
    Futoshi Sato
  • YMYasuyuki Miyakura
    Yasuyuki Miyakura
  • HHHisanaga Horie
    Hisanaga Horie
  • YYYoshikazu Yasuda
    Yoshikazu Yasuda
  • HFHirofumi Fujii
    Hirofumi Fujii
  • KKKenjiro Kotake
    Kenjiro Kotake
  • KSKokichi Sugano
    Kokichi Sugano

Open Access
Publisher website
Google Scholar
  • 3 April 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1535-7163.22501224
Abstract
No abstract available
Keywords
  • OLAPARIB
  • PARP INHIBITOR
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.